| DC10442 |
Cyazofamid
Featured
|
Cyazofamid is a foliar fungicide approved for use in the EU. |
|
| DC10775 |
Fadraciclib (CYC065)
Featured
|
CYC065 is an orally bioavailable inhibitor of cyclin dependent kinases 2, 5 and 9 (CDK2/5/9) with potential antineoplastic and chemoprotective activities. |
|
| DC7325 |
CYC116
Featured
|
CYC116 is a potent inhibitor of Aurora A/B with Ki of 8.0 nM/9.2 nM. |
|
| DC10541 |
Cyclo(RGDfC)
Featured
|
Cyclo (RGDfC), avb3 Integrin Binding Cyclic RGD Peptide,This is a cyclic RGDfC sequence, an integrin avb3-affine peptide. |
|
| DC26050 |
Cyclo(L-Pro-L-Val)
Featured
|
Cyclo(L-Pro-L-Val) is a diketopiperazine that has been found in the marine sponge T. ignis, the bacterium B. pumilus, and the fungus A. fumigatus, among others. |
|
| DC8055 |
Cyclo(-RGDfK)
Featured
|
cyclo(-RGDfK,-Arg-Gly-Asp-D-Phe-Lys)) is a selective αvβ3-integrin antagonist. |
|
| DC8399 |
Cyclo(RGDyK)
Featured
|
Cyclo(RGDyK) is a potent and selective αVβ3 integrin inhibitor with IC50 of 20 nM. |
|
| DC11446 |
Cycloastragenol
Featured
|
Cycloastragenol, the aglycone derivative of astragaloside A, can be found in various species of Astragalus and is reported to activate telomerase. |
|
| DC9058 |
Cyclobenzaprine HCl
Featured
|
Cyclobenzaprine Hcl is a skeletal muscle relaxant and a central nervous system (CNS) depressant. |
|
| DCAPI1537 |
Flunixin Meglumine
Featured
|
Cyclooxigenase inhibitor. Anti-inflammatory, analgesic and antipyretic. |
|
| DC9910 |
CYCLOPAMINE
Featured
|
Cyclopamine(11-Deoxojervine) is a specific Hedgehog (Hh) signaling pathway antagonist of Smoothened (Smo) with IC50 of 46 nM. |
|
| DC9013 |
Cyclophosphamide
Featured
|
Cyclophosphamide is a synthetic alkylating agent chemically related to the nitrogen mustards with antineoplastic and immunosuppressive activities. |
|
| DC4115 |
Cyclosporin A
Featured
|
Cyclosporin A (Cyclosporine A) is an immunosuppressant agent widely used in post-allogeneic organ transplant to reduce the activity of the immune system. |
|
| DCAPI1374 |
Cyclovirobuxin D(Bebuxine)
Featured
|
Cyclovirobuxin D(Bebuxine) |
|
| DC10610 |
CycLuc1(Luciferase substrate)
Featured
|
CycLuc1 is a luciferase substrate which offers brighter bioluminescence and improved imaging in mouse models at lower doses than the standard D-luciferin. |
|
| DC12469 |
CYH33
Featured
|
CYH33 (CYH-33) is a novel potent, PI3Kα-selective inhibitor with IC50 of 5.9 nM/598 nM/ 78.7 nM/225 nM aginst class I PI3K isoform α/β/δ/γ, respectively. |
|
| DC8088 |
CYM5442
Featured
|
CYM-5442 is a highly-selective S1P1 (Spingosine 1-Phosphate Receptor 1) agonist. |
|
| DC3107 |
Momelotinib (CYT387,CYT-387)
Featured
|
CYT387 is an ATP-competitive inhibitor of JAK1 and JAK2 with IC50 of 11 nM and 18 nM, respectively. |
|
| DC9835 |
Cytochalasin H
Featured
|
Cytochalasin H is a potent inhibitor of actin incorporation into filaments,a cell-permeable fungal toxin used in actin polymerization studies and cytological research. |
|
| DCAPI1566 |
Cytarabine hydrochloride
Featured
|
Cytosine β-D-arabinofuranoside hydrochloride is an anti-leukemic agent which binds to topoisomerase I resulting in DNA fragmentation and inhibition of replication. In addition this compound does not have any effects on RNA synthesis. Cytosine β-D-arabinof |
|
| DC10125 |
CZ415
Featured
|
CZ415 is a potent and highly selective mTOR inhibitor. |
|
| DC7734 |
CZC24832
Featured
|
CZC24832 is the first selective PI3Kγinhibitor with IC50 of 27 nM, with 10-fold selectivity over PI3Kβ and >100-fold selectivity over PI3Kα and PI3Kδ. |
|
| DC7113 |
CZC-25146
Featured
|
CZC-25146 is a potent, selective and metabolically stable LRRK2 inhibitor with IC50 of 4.76 nM/6.87 nM for wild type LRRK2 and G2019S LRRK2 respectively. |
|
| DC8082 |
CZC-54252
Featured
|
CZC-54252 is a potent inhibitor of leucine-rich repeat kinase 2 (LRRK2) (IC50 values are 1.28 nM and 1.85 nM for wild-type and G2019S mutant forms of LRRK2 respectively). |
|
| DC11199 |
CZh226
Featured
|
CZh226 hydrochloride (CZh-226) is a potent, selective inhibitor of p21-activated kinase 4 (PAK4) with Ki of 9 nM, displays 346-fold selectivity over PAK-1. |
|
| DC12252 |
D,L-Buthionine-(S,R)-sulfoximine
Featured
|
D,L-Buthionine-(S,R)-sulfoximine is a potent inhibitor of glutamylcysteine synthetase biosynthesis. |
|
| DC20219 |
D159687
Featured
|
D159687 is a selective negative allosteric modulator (NAM) of PDE4D. |
|
| DC9850 |
D-3263 HCl
Featured
|
D3263 is a novel, orally bioavailable small molecule Trp-p8 agonist. |
|
| DC7011 |
D4476 (D-4476)
Featured
|
D4476, a cell-permeant inhibitor of CK1δ (IC90 <10 uM), suppresses the site-specific phosphorylation and nuclear exclusion of FOXO1a, D4476 originally identified as inhibitors of activin receptor-like kinase ALK5. |
|
| DC9589 |
D609
Featured
|
D609 is a selective competitive phosphatidyl choline-specific phospholipase C (PC-PLC) inhibitor (Ki = 6.4 μM); antiviral and antitumor agent. |
|
